Over half of the DEN-initiated tumour samples harboured a non-synonymous mutation in the Hras proto-oncogene, almost exclusively an activating hotspot mutation in codon 61 (Fig. 6A; Table S2). The gene discussed is HRAS; the disease is neoplasm.